Objectives
Therefore, the aim of this study was to evaluate the association between insurance status and the odds of receiving definitive, guideline-recommended treatment in patients with advanced (T4) OCSCC. We additionally sought to assess whether any potential association between insurance status and treatment type changed subsequent to the introduction of the ACA. We hypothesized that patients with advanced stage disease who were uninsured or were covered by Medicaid would have lower odds of receiving definitive treatment compared to insured patients. We further hypothesized that improvement in such disparities may be appreciable after the 2014 widespread ACA expansion.